Cell Impact Q3 2023: Low demand but continued high interest

Cell Impact AB (Nasdaq First North GM: CI) reports the following summary for the third quarter 2023.The third quarter was a weak period in line with the expectations that Cell Impact communicated after the second quarter. Net sales during the third quarter of the year amounted to SEK 9.3 million (17.0) and the operating loss was SEK -23.7 million (-28.6). As communicated after the second quarter, there is lower demand for flow plates in particular. To adapt the company’s organization to these new conditions, Cell Impact implemented a cost reduction program during the third quarter that